Clinical Trials Directory

Trials / Completed

CompletedNCT02234882

Study on Pharmacokinetics

Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
50 (actual)
Sponsor
ViiV Healthcare · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effect of the coadministration of multiple doses of BMS-663068 on the systemic exposure of rosuvastatin.

Conditions

Interventions

TypeNameDescription
DRUGRosuvastatin
DRUGBMS-663068

Timeline

Start date
2014-09-05
Primary completion
2014-10-31
Completion
2014-10-31
First posted
2014-09-09
Last updated
2018-04-17

Source: ClinicalTrials.gov record NCT02234882. Inclusion in this directory is not an endorsement.

Study on Pharmacokinetics (NCT02234882) · Clinical Trials Directory